BBI becomes notch on Inverness' ever-growing acquisitions list
This article was originally published in Clinica
Executive Summary
UK diagnostic test and reagents developer BBI has agreed to a £83.7m ($170.6m) takeover by its long-term partner Inverness Medical Innovations.